ApicHope(SZ:300723) Xin Lang Cai Jing·2025-10-31 02:58Group 1 - The core viewpoint of the news is that Yipinhong Pharmaceutical Group Co., Ltd. experienced a stock price increase of 5.72%, reaching 53.79 CNY per share, with a trading volume of 290 million CNY and a turnover rate of 1.32%, resulting in a total market capitalization of 24.297 billion CNY [1] - Yipinhong was established on February 4, 2002, and listed on November 16, 2017. The company focuses on the research, production, and sales of its own pharmaceuticals, as well as the sales of agency drugs [1] - The main revenue composition of Yipinhong includes children's medicine at 61.12%, chronic disease medicine at 22.71%, and other products at 16.17% [1] Group 2 - From the perspective of major circulating shareholders, Guangfa Fund has a fund that ranks among the top ten circulating shareholders of Yipinhong. Guangfa Healthcare Stock A (004851) newly entered the top ten in the third quarter, holding 3.0452 million shares, which accounts for 0.73% of the circulating shares [2] - Guangfa Healthcare Stock A (004851) was established on August 10, 2017, with a latest scale of 5.185 billion CNY. The fund has achieved a return of 16.65% this year, ranking 3170 out of 4216 in its category, and a return of 14.13% over the past year, ranking 3091 out of 3889 [2] - The fund manager of Guangfa Healthcare Stock A is Wu Xingwu, who has a cumulative tenure of 10 years and 265 days, with a total fund asset scale of 10.641 billion CNY. The best fund return during his tenure is 100.05%, while the worst is -38.35% [2] Group 3 - From the perspective of the fund's top heavy positions, Guangfa Healthcare Stock A (004851) holds 3.0452 million shares of Yipinhong, accounting for 3.02% of the fund's net value, making it the ninth largest heavy position [3] - The estimated floating profit from this position is approximately 8.8616 million CNY [3]